Alcon lens implant approved for cataract surgery

The Food and Drug Administration (FDA) recently approved a new replacement lens for cataract patients. The new lens combines treatment for both¬†astigmatism and presbyopia. This allows the patient to depend less on prescription eyewear. The new lens offered by Alcon is the only multi-focal intraocular lens where the central portion is completely dedicated to distance […]

Eye injections increase glaucoma risk

Patients who receive seven or more Intravitreous eye injections of bevacizumab (Avastin) each year are at a higher risk of eventually needing glaucoma surgery according to study results recently published in the JAMA Ophthalmology medical journal. Intravitreous injections are the standard therapy for patients suffering from the wet form of macular degeneration. Researchers examined data […]

Some unproven stem cell treatments can cause blindness

Stem cell therapy is a hot topic in the news and the hope that stem cell therapy provides as a potential treatment for macular degeneration has resulted in clinics across the country providing unproven treatments. Recently, three elderly women underwent an unapproved stem cell therapy at a Florida clinic and within a week of receiving, […]

Steroids for macular degeneration?

It is a known fact that inflammation plays a role in the progression of age-related macular degeneration (AMD), but using steroids to treat AMD has not yet been shown to have any demonstrable effect on the disease. Doctors have tried various anti-inflammatory drugs to try and inhibit the inflammation of AMD with little success. Many […]

Tiny eye implant may help blind people

Researchers at the University of California, San Diego have developed a high-resolution retinal prosthesis that uses nanowires and wireless electronics to assist neurons in the retina in responding to light. The device will aid people suffering from eye diseases such as macular degeneration, and retinitis pigmentosa. This new device differs from current retinal prostheses in […]

Testing of drug underway for patients with wet macular degeneration

A new drug that is currently being tested on mice and rabbits requires fewer injections than the current standard intravitreal therapy for age-related macular degeneration (AMD). Researchers are hopeful that injections in humans would have a longer-lasting effect: several months between injections instead of every four to six weeks. The new drug lasted two months […]

Brain-implanted device generates images

The revolutionary retinal prosthesis, the Argus, was developed by Second Sight and works by gathering imagery from a camera that is built into glasses worn by the patient. The imagery is passed to an electrode array that has been implanted into the retina of the patient. These signals from the array travel the optic nerve […]

iPad game effective in treating lazy eye

Patching the unaffected eye has been the standard treatment for amblyopia (lazy eye) but a special iPad game has been found to be more effective than patching. A study was recently published in the online JAMA Ophthalmology.¬† Researchers at the Retina Foundation in Dallas randomly assigned 28 children diagnosed with amblyopia to treatment using a […]

New treatment for uveitis

A recent study published in the New England Journal of Medicine details the findings that the arthritis medication, adalimumab, can effectively treat uveitis. Researchers were looking to determine what effect adalimumab has on patients with uveitis. Adalimumab is a steroid-free, injection that has few side effects and is used to treat rheumatic diseases. 217 adults […]

Improved therapy for retinoblastoma patients

The addition of topotecan to a multi-drug chemotherapy helped to maintain high cure rates for the devastating eye cancer and helped preserve vision and reduced the likelihood of developing treatment-related leukemia. Results of the 10-year follow-up study were recently published online in the Journal of Clinical Oncology. Retinoblastoma is an eye cancer that occurs in […]